Quality Improvement in Neurology: Headache Quality Measurement Set

Overview

Journal Neurology

Specialty Neurology

Date 2020 Sep 24

PMID 32967929

Citations 3

Authors

Matthew S Robbins

M Cristina Victorio

Mark Bailey

Calli Cook

Ivan Garza

J Stephen Huff

Duren Ready

Nathaniel M Schuster

David Seidenwurm

Elizabeth Seng

Christina Szperka

Erin Lee

Raissa Villanueva

Affiliations

Soon will be listed here.

Citing Articles

Education Research: Exploring the Impact of Standardized, Condition-Specific Note Templates on Quality Metrics and Efficiency in Multiple Resident Clinics.

Breithaupt A, Mohan S, Thombley R, Pimentel S, Douglas V Neurol Educ. 2025; 4(1):e200200.

PMID: 40070448 PMC: 11896599. DOI: 10.1212/NE9.0000000000200200.

Understanding Data and Opportunities Focused on Value: A Single-Center Experience in Headache Care.

Wilson A, Sylvia M, DAbreu A, Hansen C, Salah-Ud-Din M, Ahmed A Neurol Clin Pract. 2024; 15(1):e200347.

PMID: 39399561 PMC: 11464221. DOI: 10.1212/CPJ.0000000000200347.

Establishing content validity for the migraine Global Impression Item (mGI-I) assessment: a modified single-item migraine symptom severity questionnaire.

Chandler D, Navetta M, Shah S, Cline J, Phinney M BMC Neurol. 2022; 22(1):103.

PMID: 35303826 PMC: 8932152. DOI: 10.1186/s12883-022-02626-0.

Quality Improvement in Neurology: Headache Quality Measurement Set.

Neurology. 2021; 96(20):969.

PMID: 33431516 PMC: 8589296. DOI: 10.1212/WNL.0000000000011419.

References

. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018; 38(1):1-211. DOI: 10.1177/0333102417738202. View

Lademann V, Jansen J, Evers S, Frese A . Evaluation of guideline-adherent treatment in cluster headache. Cephalalgia. 2015; 36(8):760-4. DOI: 10.1177/0333102415612774. View

Robbins M . The psychiatric comorbidities of cluster headache. Curr Pain Headache Rep. 2013; 17(2):313. DOI: 10.1007/s11916-012-0313-8. View

Seng E, Holroyd K . Optimal use of acute headache medication: a qualitative examination of behaviors and barriers to their performance. Headache. 2013; 53(9):1438-50. DOI: 10.1111/head.12157. View

. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017; 390(10100):1211-1259. PMC: 5605509. DOI: 10.1016/S0140-6736(17)32154-2. View

Ross S, Wall E, Schierman B, Bailey J, Cheng E, Flippen 2nd C . Quality improvement in neurology: primary headache quality measures. Neurology. 2015; 84(2):200-3. PMC: 4336086. DOI: 10.1212/WNL.0000000000001134. View

Lipton R, Fanning K, Serrano D, Reed M, Cady R, Buse D . Ineffective acute treatment of episodic migraine is associated with new-onset chronic migraine. Neurology. 2015; 84(7):688-95. PMC: 4336107. DOI: 10.1212/WNL.0000000000001256. View

Buse D, Manack A, Fanning K, Serrano D, Reed M, Turkel C . Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study. Headache. 2012; 52(10):1456-70. DOI: 10.1111/j.1526-4610.2012.02223.x. View

Sjostrand C, Alexanderson K, Josefsson P, Steinberg A . Sickness absence and disability pension days in patients with cluster headache and matched references. Neurology. 2020; 94(21):e2213-e2221. DOI: 10.1212/WNL.0000000000009016. View

10.

Evans R, Burch R, Frishberg B, Marmura M, Mechtler L, Silberstein S . Neuroimaging for Migraine: The American Headache Society Systematic Review and Evidence-Based Guideline. Headache. 2020; 60(2):318-336. DOI: 10.1111/head.13720. View

11.

Schwedt T, Alam A, Reed M, Fanning K, Munjal S, Buse D . Factors associated with acute medication overuse in people with migraine: results from the 2017 migraine in America symptoms and treatment (MAST) study. J Headache Pain. 2018; 19(1):38. PMC: 5968010. DOI: 10.1186/s10194-018-0865-z. View

12.

Turner S, Rende E, Pezzuto T, Weaver S, Henderlong-Kropp A, Greene K . Pediatric Migraine Action Plan (PedMAP). Headache. 2019; 59(10):1871-1873. PMC: 7331055. DOI: 10.1111/head.13681. View

13.

Gibbs T, Fleischer Jr A, Feldman S, Sam M, ODonovan C . Health care utilization in patients with migraine: demographics and patterns of care in the ambulatory setting. Headache. 2003; 43(4):330-5. DOI: 10.1046/j.1526-4610.2003.03067.x. View

14.

Peretz A, Minen M, Cowan R, Strauss L . Migraine Action Plan (MAP). Headache. 2018; 58(2):355-356. DOI: 10.1111/head.13255. View

15.

Chiang C, Schwedt T, Wang S, Dodick D . Treatment of medication-overuse headache: A systematic review. Cephalalgia. 2015; 36(4):371-86. DOI: 10.1177/0333102415593088. View

16.

Silberstein S, Holland S, Freitag F, Dodick D, Argoff C, Ashman E . Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. 2012; 78(17):1337-45. PMC: 3335452. DOI: 10.1212/WNL.0b013e3182535d20. View

17.

Bigal M, Borucho S, Serrano D, Lipton R . The acute treatment of episodic and chronic migraine in the USA. Cephalalgia. 2009; 29(8):891-7. DOI: 10.1111/j.1468-2982.2008.01819.x. View

18.

Peters M, Abu-Saad H, Vydelingum V, Dowson A, Murphy M . Patients' decision-making for migraine and chronic daily headache management. A qualitative study. Cephalalgia. 2003; 23(8):833-41. DOI: 10.1046/j.1468-2982.2003.00590.x. View

19.

Louter M, Wilbrink L, Haan J, van Zwet E, van Oosterhout W, Zitman F . Cluster headache and depression. Neurology. 2016; 87(18):1899-1906. DOI: 10.1212/WNL.0000000000003282. View

20.

Scher A, Rizzoli P, Loder E . Medication overuse headache: An entrenched idea in need of scrutiny. Neurology. 2017; 89(12):1296-1304. DOI: 10.1212/WNL.0000000000004371. View